Retatrutide vs Tirzepatide: A Research Comparison

Quick Summary

• Retatrutide is a triple agonist (GLP-1 + GIP + Glucagon), while Tirzepatide is dual (GLP-1 + GIP).
• Published trials have compared body-weight endpoints for both compounds; Retatrutide adds glucagon receptor activity.
• Both are long-acting; researchers study whether Retatrutide’s glucagon component affects energy expenditure and thermogenesis.
• Peptides Lab UK offers COA-verified research peptides, including both compounds.

What Are Retatrutide and Tirzepatide?

Both peptides are part of the incretin-mimetic class, developed to mimic gut hormones that regulate blood sugar, appetite, and fat metabolism.

• Tirzepatide (branded as Mounjaro) is FDA-approved and targets GLP-1 and GIP receptors.
• Retatrutide is under clinical development and targets GLP-1, GIP, and glucagon receptors — making it a triple agonist.

Mechanism of Action: Triple vs Dual Agonis

Feature	Tirzepatide	Retatrutide
GLP-1 Activation	✅ Appetite & insulin	✅ Appetite & insulin
GIP Activation	✅ Fat metabolism	✅ Fat metabolism
Glucagon Target	❌ No	✅ Studied for energy expenditure
Fat oxidation / thermogenesis research	Studied	Studied (glucagon-linked)

Source: NEJM Retatrutide Study | Tirzepatide Study

Published Clinical-Stage Research

✅ Tirzepatide (SURPASS trials):

• Investigated glycaemic and body-weight endpoints in the published SURPASS programme
• Approved for type 2 diabetes
• Tolerability: mild to moderate GI effects

✅ Retatrutide (Phase 2 data):

• Investigated body-weight and metabolic endpoints in published Phase 2 studies
• Investigational; not yet approved
• Higher energy expenditure + glucagon-driven fat mobilization

Retatrutide vs Tirzepatide Dosage Comparison

Week	Tirzepatide (mg)	Retatrutide (mg)
1–2	2.5	1.0
3–4	5.0	2.5
5–6	7.5	5.0
7–8	10.0	7.5
9–12	12.5–15.0	10.0–15.0

Both follow slow titration (every 2–4 weeks) for optimal tolerability.

Legal Status and Use in Research

• Tirzepatide has regulatory approval for type 2 diabetes.
• Retatrutide is investigational and available only for research purposes.
• In the UK and Ireland, both peptides can be legally purchased for research use through verified suppliers.

Buy Research-Grade Retatrutide and Tirzepatide

Peptides Lab UK supplies both peptides with:

• ✅ Verified COA on each batch
• ✅ 99%+ purity
• ✅ Fast UK/Ireland shipping
• ✅ Research-use-only compliant packaging

Frequently Asked Questions (FAQs)

What is the main mechanistic difference between Retatrutide and Tirzepatide?

Retatrutide adds glucagon receptor activation to the GLP-1 and GIP activity shared with Tirzepatide; researchers study what this third pathway contributes.

Are both peptides long-acting?

Yes. Both Retatrutide and Tirzepatide have extended half-lives in pharmacokinetic studies.

Are either of these peptides approved for human use?

Only Tirzepatide is FDA approved. Retatrutide is for research only and not for human use.

Disclaimer

This content is for research and educational purposes only. Retatrutide and Tirzepatide are investigational compounds and not approved for human consumption.